Forte Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FBRX and buy or sell other stocks, ETFs, and their options commission-free!About FBRX
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis.
CEOPaul A. Wagner
CEOPaul A. Wagner
Employees9
Employees9
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2017
Founded2017
Employees9
Employees9
FBRX Key Statistics
Market cap2.81B
Market cap2.81B
Price-Earnings ratio-10.07
Price-Earnings ratio-10.07
Dividend yield—
Dividend yield—
Average volume380.44K
Average volume380.44K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.9149
52 Week high$0.9149
52 Week low$0.2796
52 Week low$0.2796
Stock Snapshot
Forte Biosciences(FBRX) stock is priced at $76.99, giving the company a market capitalization of 2.81B. It carries a P/E multiple of -10.07.
During the trading day, Forte Biosciences(FBRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Forte Biosciences(FBRX) stock has reached 0, versus its average volume of 380.44K.
The stock's 52-week range extends from a low of $0.28 to a high of $0.91.
The stock's 52-week range extends from a low of $0.28 to a high of $0.91.
People also own
Based on the portfolios of people who own FBRX. This list is generated using Robinhood data, and it’s not a recommendation.